Complementation of two mutant p53: Implications for loss of heterozygosity in cancer

被引:8
|
作者
Demidenko, ZN
Fojo, T
Blagosklonny, MV
机构
[1] New York Med Coll, Brander Canc Res Inst, Valhalla, NY 10595 USA
[2] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源
FEBS LETTERS | 2005年 / 579卷 / 10期
关键词
cancer; p53; tumor suppressor;
D O I
10.1016/j.febslet.2005.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Remarkably, a cancer cell rarely possesses two mutant p53 proteins. Instead, mutation of one allele is usually associated with loss of the second p53 allele. Why do not two mutant p53 co-exist? We hypothesize that two different p53 may complement each other, when expressed at equal levels. By titrating trans-deficient and DNA-binding-deficient p53 in cells with mutant p53 and by co-transfecting distinct mutant p53 in p53-null cells, we demonstrated activation of p53-dependent transcription. We suggest that, due to complementation of two mutant p53, cancer cells need to delete the second p53 allele rather than mutate it. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.Ni. All rights reserved.
引用
收藏
页码:2231 / 2235
页数:5
相关论文
共 50 条
  • [41] p53 polymorphisms: cancer implications
    Whibley, Catherine
    Pharoah, Paul D. P.
    Hollstein, Monica
    NATURE REVIEWS CANCER, 2009, 9 (02) : 95 - 107
  • [42] A Chimeric p53 Evades Mutant p53 Transdominant Inhibition in Cancer Cells
    Okal, Abood
    Mossalam, Mohanad
    Matissek, Karina J.
    Dixon, Andrew S.
    Moos, Philip J.
    Lim, Carol S.
    MOLECULAR PHARMACEUTICS, 2013, 10 (10) : 3922 - 3933
  • [43] p53 polymorphisms: cancer implications
    Catherine Whibley
    Paul D. P. Pharoah
    Monica Hollstein
    Nature Reviews Cancer, 2009, 9 : 95 - 107
  • [44] Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas
    Schiebe, M
    Ohneseit, P
    Hoffmann, W
    Meyermann, R
    Rodemann, HP
    Bamberg, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (05) : 325 - 328
  • [45] Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas
    Martina Schiebe
    Petra Ohneseit
    Wolfgang Hoffmann
    Richard Meyermann
    Hans-Peter Rodemann
    Michael Bamberg
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 325 - 328
  • [46] Loss of wild-type p53 promotes colon cancer metastasis that express gain-of-function mutant p53
    Nakayama, Mizuho
    Hong, Chang Pyo
    Oshima, Hiroko
    Sakai, Eri
    Kim, Seong-Jin
    Oshima, Masanobu
    CANCER SCIENCE, 2021, 112 : 265 - 265
  • [47] Network Effect of Wt-mutant p53 Interactions and Implications on p53 Gene Therapy
    Ji, Xiaona
    Ma, Lijie
    Huang, Qiang
    Li, Zijuan
    Zhao, Jing
    Huang, Weixue
    Ma, Buyong
    Yu, Long
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (08) : 1259 - 1267
  • [48] Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators
    Balourdas, Dimitrios-Ilias
    Markl, Anja M.
    Kraemer, Andreas
    Settanni, Giovanni
    Joerger, Andreas C.
    CELL DEATH & DISEASE, 2024, 15 (06):
  • [49] Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer
    Suzuki, M
    Saito, S
    Saga, Y
    Ohwada, M
    Sato, I
    MEDICAL ONCOLOGY, 1998, 15 (02) : 119 - 123
  • [50] The Contrived Mutant p53 Oncogene - Beyond Loss of Functions
    Sabapathy, Kanaga
    FRONTIERS IN ONCOLOGY, 2015, 5